2018. Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis. Farmeconomia. Health economics and therapeutic pathways. 19, 1 (Nov. 2018). DOI:https://doi.org/10.7175/fe.v19i1.1385.